Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Formula | C15H13N5OS |
||||||
Molecular Weight | 311.36 | CAS No. | 1226056-71-8 | ||||
Solubility (25°C)* | In vitro | DMSO | 63 mg/mL (202.33 mM) | ||||
Water | Insoluble | ||||||
Ethanol | Insoluble | ||||||
In vivo (Add solvents to the product individually and in order) |
|
||||||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
Description | Thiazovivin is a novel ROCK inhibitor with IC50 of 0.5 μM in a cell-free assay, promotes hESC survival after single-cell dissociation. | ||
---|---|---|---|
Targets |
|
||
In vitro | Although displaying little impact on cell proliferation, Thiazovivin treatment significantly enhances the survival of human embryonic stem cells (hESCs) after enzymatic dissociation more than 30-fold, while homogenously maintaining pluripotency with the characteristic colony morphology, expression of typical pluripotency markers such as alkaline phosphatase (ALP), and normal karyotype. Dissociated hESCs treated with Thiazovivin display dramatically increased adhesion to matrigel- or laminin-coated plates but not to gelatin-coated plates within a few hours. Thiazovivin treatment increases cell-ECM adhesion-mediated β1 integrin activity, which synergizes with growth factors to promote cell survival. In addition to activating integrin, Thiazovivin but not Tyrintegin (Ptn) protects hESCs from death in the absence of ECM in suspension through E-cadherin-mediated cell-cell interaction. Thiazovivin treatment potently inhibits endocytosis of E-cadherin, consequently stabilizing E-cadherin on the cell surface and leading to reestablishment of cell-cell interaction, which is essential for hESC survival in ECM-free conditions. Thiazovivin but not Tyrintegin (Ptn) at 2 μM inhibits Rho-associated kinase (ROCK) activity and protects hESCs at a similar level as the widely used selective ROCK inhibitor Y-27632 at 10 μM, suggesting that Rho-ROCK signaling regulates cell-ECM and cell-cell adhesion. [1] Thiazovivin at 1 μM increases the reprogramming efficiency of CB mononuclear cells to induced pluripotent stem cells (iPSCs) by more than 10 times. [2] |
Kinase Assay: |
|
---|---|
Cell Assay: |
|
Data from [Arch Toxicol, 2013, 87(12), 2215-31]
Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells [ Nat Biotechnol, 2024, 10.1038/s41587-024-02360-7] | PubMed: 39223325 |
METTL3/METTL14 maintain human nucleoli integrity by mediating SUV39H1/H2 degradation [ Nat Commun, 2024, 15(1):7186] | PubMed: 39169036 |
HBO1 determines SMAD action in pluripotency and mesendoderm specification [ Nucleic Acids Res, 2024, gkae158] | PubMed: 38421638 |
Generation of human vascularized and chambered cardiac organoids for cardiac disease modelling and drug evaluation [ Cell Prolif, 2024, e13631.] | PubMed: 38453465 |
RNA m6A modification regulates L1 retrotransposons in human spermatogonial stem cell differentiation in vitro and in vivo [ Cell Mol Life Sci, 2024, 81(1):92] | PubMed: 38363375 |
Telomerase is essential for cardiac differentiation and sustained metabolism of human cardiomyocytes [ Cell Mol Life Sci, 2024, 81(1):196] | PubMed: 38658440 |
Feeder-free generation and characterization of endocardial and cardiac valve cells from human pluripotent stem cells [ iScience, 2024, 27(1):108599] | PubMed: 38170020 |
Large-scale generation of IL-12 secreting macrophages from human pluripotent stem cells for cancer therapy [ Mol Ther Methods Clin Dev, 2024, 32(1):101204] | PubMed: 38390556 |
Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy [ Stem Cell Res, 2024, 78:103467] | PubMed: 38861774 |
Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation [ Stem Cell Res, 2024, 77:103404] | PubMed: 38552356 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.